🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers
VCCircle
·
8m ago
Medial
Aragen Life Sciences, a drug development and manufacturing company backed by Goldman Sachs, is reportedly considering an initial public offering (IPO) and is engaging in talks with bankers. The company, previously known as GVK Biosciences, has undergone a name change and is assessing the potential of going public. Aragen offers contract drug development and manufacturing services.
View Source
Related News
Grapevine: Aragen Life, Urban Company investors weigh stake sale
VCCircle
·
11m ago
Medial
Promoters and investors of Aragen Life Sciences are considering selling a 10% stake in a pre-IPO round, valuing the company at around $1.5 billion. Potential investors, such as Quadria Capital and Novo Nordisk, are reported to be in early talks for a minority stake. Aragen Life Sciences is a contract research organization (CRO) that has received backing from Goldman Sachs.
View Source
Avendus Fund leads Rs 300 Cr investment in Aragen Life Sciences
YourStory
·
23d ago
Medial
Avendus Future Leaders Fund III led a Rs 300 crore investment in Aragen Life Sciences, a major Indian CRDMO. Partnered with SBI Life Insurance, the fund acquired a minority stake. Avendus's second investment, following La Renon Healthcare, highlights confidence in India's growing CRDMO sector amid increased global outsourcing. Aragen, backed by investors like Goldman Sachs, aims to enhance its services for global pharma innovations with this funding, strengthening its market position further.
View Source
Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen
VCCircle
·
7m ago
Medial
Quadria Capital, a healthcare-focused private equity firm, is investing $100 million in Hyderabad-based Aragen Life Sciences, a contract drug development and manufacturing company. This investment includes a fresh capital infusion and a small component of share sales by existing shareholders. Aragen plans to use the funds to expand its capabilities to meet increasing demand in the US and Europe. The investment is considered a pre-IPO fundraise as Aragen is exploring an initial public offering.
View Source
TPG-backed Sai Life Sciences plans IPO with Rs 800 Cr fresh issue, OFS
YourStory
·
1y ago
Medial
Sai Life Sciences, backed by private equity firm TPG Capital, has filed preliminary papers for an initial public offering (IPO). The IPO will consist of a fresh issue of equity shares worth INR 800 crore and an offer-for-sale of 6.15 crore shares by existing shareholders. The proceeds will be used for debt repayment and general corporate purposes. Sai Life Sciences offers services across the drug discovery, development, and manufacturing value chain and operates in the rapidly growing Indian CRDMO (contract research, development, and manufacturing organization) market. Kotak Mahindra Capital, IIFL Securities, Jefferies India, and Morgan Stanley India have been appointed as merchant bankers for the IPO.
View Source
Grapevine: Blackstone, Horizon Industrial, Goldman Sachs, PeopleStrong in news
VCCircle
·
8m ago
Medial
Blackstone is reportedly planning to launch an IPO for Horizon Industrial Parks, while Goldman Sachs is in talks to acquire a majority stake in PeopleStrong.
View Source
Inside Avendus’ strategy to tap India’s next wave of unicorns
Livemint
·
23d ago
Medial
Avendus Future Leaders Fund (FLF) has invested ₹300 crore in Aragen Life Sciences alongside SBI Life Insurance, each contributing ₹150 crore. This marks FLF’s second healthcare investment this year, following a previous stake in La Renon Healthcare. The investment was made from FLF III, reflecting the fund's ongoing interest and commitment to the healthcare sector.
View Source
boAt to launch $300-500 million IPO in next fiscal: Report
Inshorts
·
9m ago
Medial
Homegrown wearable and audio brand boAt is aiming to launch its $300-500 million IPO in the next fiscal, ET reported. ICICI Securities, Goldman Sachs and Nomura have been selected as bankers for the public offering, with boAt potentially eyeing valuation above $1.5 billion. boAt had initially filed for a public offering in 2022 but paused due to unfavourable market conditions.
View Source
Ola plans $500 million IPO, to appoint banks soon
Economic Times
·
1y ago
Medial
Indian ride-hailing company Ola is planning to raise $500 million in an initial public offering (IPO) that would value the company at around $5 billion. The SoftBank-backed company aims to file the necessary papers with India's market regulator within three months. Ola is in talks with several investment banks, including Goldman Sachs and Bank of America, and plans to appoint IPO advisers in the near future. This would be Ola's second attempt at an IPO, after a planned $1 billion fundraising in 2021 was scrapped. The company's investors have recently lowered its valuation to $1.9 billion.
View Source
Prosus Eyes PayU IPO In 2025
Inc42
·
9m ago
Medial
PayU, a payments solutions provider, has decided to delay its initial public offering (IPO) until 2025. Prosus, the investor, had initially considered PayU's IPO for 2024. PayU has selected Goldman Sachs as one of the lead bankers for the IPO and plans to file its draft red herring prospectus (DRHP) by early 2025. Prosus, meanwhile, has expressed confidence in its India portfolio, citing strong gains from Swiggy's recent IPO and a promising pipeline of potential IPOs in the country.
View Source
Urban Company secures shareholder nod for IPO, to raise Rs 528 crore in fresh capital
Economic Times
·
4m ago
Medial
Urban Company has received shareholder approval for an IPO to raise Rs 528 crore in fresh capital. Initially targeting a Rs 3,000 crore IPO, the company adjusted its plans due to market conditions. The IPO will include both primary capital raise and an offer-for-sale from investors. Urban Company has appointed Kotak Mahindra, Goldman Sachs, and Morgan Stanley as bankers. The company narrowed its net loss in fiscal 2024 and reported a pre-tax profit in early 2025.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
Aug 2025
Jurifly
Build. Comply. Fund. Fly.
FloatFi App
Crypto to INR payments app for Indians
ForkMyCV
Your CV, Done Right.
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
